Hospital da Luz; Departamento de Oncologia Medica
About Hospital da Luz; Departamento de Oncologia Medica
"O Hospital da Luz Lisboa tem disponível: consultas, exames de diagnóstico, análises clínicas, cirurgias, internamento, atendimento urgente, maternidade, entre outros serviços médicos. Para mais informações, por favor consulte o website. Caso tenha uma consulta ou exame marcado e tem tosse, febre, dificuldade respiratória, perdeu o olfato ou o sabor, se está em confinamento, se teve contacto com um doente infetado, antes de vir ao Hospital da Luz entre em contacto com a LUZ 24 (217 104 424) - serviço gratuito de triagem clínica do Hospital da Luz para adultos e crianças, disponível 24 horas/365 dias."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Genentech, Inc.
1
Clinical Trials at Hospital da Luz; Departamento de Oncologia Medica
During the past decade, Hospital da Luz; Departamento de Oncologia Medica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
2012-12-03
2017-05-31
Terminated
182
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
2015-04-09
2021-06-29
Terminated
631
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
2018-12-19
2022-10-12
Completed
160
A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.
2019-11-25
2023-02-28
Completed
242
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital da Luz; Departamento de Oncologia Medica"
#1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hospital da Luz; Departamento de Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Hospital da Luz; Departamento de Oncologia Medica" are
"Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials), "Gastric Cancer" (1 trials) and "HER2-Positive Early Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital da Luz; Departamento de Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Hospital da Luz; Departamento de Oncologia Medica
Most popular intervention types in "Hospital da Luz; Departamento de Oncologia Medica" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Docetaxel" (2 trials), "Pertuzumab" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital da Luz; Departamento de Oncologia Medica
The vast majority of trials in "Hospital da Luz; Departamento de Oncologia Medica" are
10 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital da Luz; Departamento de Oncologia Medica
Currently, there are NaN active trials in "Hospital da Luz; Departamento de Oncologia Medica".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hospital da Luz; Departamento de Oncologia Medica,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital da Luz; Departamento de Oncologia Medica, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".